UBS Maintains a 'Neutral' on Level 3 Communications (LVLT); Lowering PT & Estimates on Macro Concerns
Get Alerts LVLT Hot Sheet
Price: $53.63 --0%
Rating Summary:
14 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
14 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
UBS maintains a 'Neutral' on Level 3 Communications (NASDAQ: LVLT) price target lowered from $2.50 to $1.80.
UBS analyst says, "On track to close Global Crossing (Nasdaq: GLBC) deal by YE11...Businesses still pulling back on spending...We have tweaked revenue growth, capex and margin assumptions to reflect the tougher competitive environment and investments/hiring Level 3 may need to make to keep provisioning intervals where they are. This is key to keeping customer churn under control as the merger integration process begins. Given the changes to our model, 2012E EPS falls to -$0.30 from - $.0.27 while 2013E goes to -$0.24 from -$0.19."
For more ratings news on Level 3 Communications click here and for the rating history of Level 3 Communications click here.
Shares of Level 3 Communications closed at $1.56 yesterday.
UBS analyst says, "On track to close Global Crossing (Nasdaq: GLBC) deal by YE11...Businesses still pulling back on spending...We have tweaked revenue growth, capex and margin assumptions to reflect the tougher competitive environment and investments/hiring Level 3 may need to make to keep provisioning intervals where they are. This is key to keeping customer churn under control as the merger integration process begins. Given the changes to our model, 2012E EPS falls to -$0.30 from - $.0.27 while 2013E goes to -$0.24 from -$0.19."
For more ratings news on Level 3 Communications click here and for the rating history of Level 3 Communications click here.
Shares of Level 3 Communications closed at $1.56 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
- Regeneron Pharma (REGN) PT Raised to $756 at Bernstein SocGen Group
- Cellebrite (CLBT) PT Lowered to $15 at DA Davidson Following Q2 Miss
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share